An experimental Ebola vaccine appears safe and triggered signs of immune protection in the first 20 volunteers to test it, U.S. researchers reported Wednesday.
The U.S. Food and Drug Administration will allow an unapproved blood-transfusion system to be made available in an effort to increase the availability of plasma from Ebola survivors to treat newly infected patients.
Some low-cost generic drugs that have helped restrain healthcare costs for decades are seeing unexpected price spikes of up to 8,000%, prompting a backlash from patients, pharmacists and now lawmakers.
The Justice Department recovered $2.3 billion from alleged healthcare fraud schemes in fiscal 2014, down slightly from the $2.6 million it collected the year before, it announced Thursday morning.
The Drug Enforcement Administration's recent decision to reclassify Vicodin and similar hydrocodone combination drugs to Schedule II controlled substances is a significant step in fighting the prescription-drug abuse epidemic, but I'm concerned the tighter controls may place undue burdens on...
How much does it cost to get a drug approved? A new estimate puts the number at $2.55 billion, more than twice the cost assessed by the same lead researcher a decade ago. Not everyone believes the math.
Actavis, which is buying Botox-maker Allergan for $66 billion in one of the biggest acquisitions announced so far this year, plans to stay committed to developing new products.
The long-awaited results of a trial of the cholesterol-lowering drug Vytorin showed modest benefit and indicated that adding a non-statin drug to a statin therapy regimen may help high-risk patients with acute coronary syndrome safely achieve lower cholesterol levels.
Millions of people with stents that prop open clogged heart arteries may need anti-clotting drugs much longer than the one year doctors recommend now. A large study found that continuing for another 18 months lowers the risk of heart attacks, clots and other problems.
HHS has scrapped plans to issue sweeping regulations clarifying the federal 340B drug discount program in light of a court ruling against another 340B rule challenged by the pharmaceutical industry.
Swiss drugmaker Roche said Friday that the Food and Drug Administration approved its drug Avastin as a treatment for ovarian cancer. Roche said the FDA approved Avastin in combination with chemotherapy as a treatment for recurrent cases of cancer that are resistant to platinum-based chemotherapy.
Voters in a number of states decided on a variety of hotly contested state ballot initiatives last week, including measures to regulate health insurance rate increases, hike medical liability damage caps, restrict abortions, make experimental medical treatments more available to patients, and...